WFIKKN2
WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2
Also known as: WFDC20B, WFIKKNRP, WFKN2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TEU8
- Gene
- WFIKKN2
- Ensembl
- ENSG00000173714
- Chromosome
- 17
- Canonical length
- 576 aa
- Protein class
- Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
The WFIKKN1 protein contains a WAP domain, follistatin domain, immunoglobulin domain, two tandem Kunitz domains, and an NTR domain. This gene encodes a WFIKKN1-related protein which has the same domain organization as the WFIKKN1 protein. The WAP-type, follistatin type, Kunitz-type, and NTR-type protease inhibitory domains may control the action of multiple types of proteases. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
576 residues, UniProt reviewed canonical sequence.
>Q8TEU8|WFIKKN2
1 MWAPRCRRFW SRWEQVAALL LLLLLLGVPP RSLALPPIRY SHAGICPNDM NPNLWVDAQS
61 TCRRECETDQ ECETYEKCCP NVCGTKSCVA ARYMDVKGKK GPVGMPKEAT CDHFMCLQQG
121 SECDIWDGQP VCKCKDRCEK EPSFTCASDG LTYYNRCYMD AEACSKGITL AVVTCRYHFT
181 WPNTSPPPPE TTMHPTTASP ETPELDMAAP ALLNNPVHQS VTMGETVSFL CDVVGRPRPE
241 ITWEKQLEDR ENVVMRPNHV RGNVVVTNIA QLVIYNAQLQ DAGIYTCTAR NVAGVLRADF
301 PLSVVRGHQA AATSESSPNG TAFPAAECLK PPDSEDCGEE QTRWHFDAQA NNCLTFTFGH
361 CHRNLNHFET YEACMLACMS GPLAACSLPA LQGPCKAYAP RWAYNSQTGQ CQSFVYGGCE
421 GNGNNFESRE ACEESCPFPR GNQRCRACKP RQKLVTSFCR SDFVILGRVS ELTEEPDSGR
481 ALVTVDEVLK DEKMGLKFLG QEPLEVTLLH VDWACPCPNV TVSEMPLIIM GEVDGGMAML
541 RPDSFVGASS ARRVRKLREV MHKKTCDVLK EFLGLHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against WFIKKN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 1,103 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 1,103 nTPM
- ovary: 144 nTPM
- pituitary gland: 2.2 nTPM
- testis: 2.2 nTPM
- skeletal muscle: 2 nTPM
- cerebellum: 1.9 nTPM
Single-cell type
- peritubular myoid cells: 22 nCPM
- ovarian stromal cells: 22 nCPM
- leydig cells: 9.3 nCPM
- oocytes: 9.2 nCPM
- granulosa cells: 6.5 nCPM
- choroid plexus epithelial cells: 4 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 1,253 nTPM
- hippocampal formation: 18 nTPM
- thalamus: 11 nTPM
- cerebellum: 11 nTPM
- amygdala: 4.8 nTPM
- white matter: 3.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.76
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.21
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- muscle cell development
- negative regulation of transforming growth factor beta receptor signaling pathway
- roof of mouth development
- skeletal system development
- transforming growth factor beta receptor signaling pathway
Molecular functions
- receptor antagonist activity
- serine-type endopeptidase inhibitor activity
- transforming growth factor beta binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Netrin domain
- Pancreatic trypsin inhibitor Kunitz domain
- Kazal domain
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Immunoglobulin-like domain
- WAP-type 'four-disulfide core' domain
- Tissue inhibitor of metalloproteinases-like, OB-fold
- Immunoglobulin I-set
- Immunoglobulin-like fold
- Netrin module, non-TIMP type
- Proteinase inhibitor I2, Kunitz, conserved site
- WFIKKN1/2, immunoglobulin-like domain 3
- Kazal domain superfamily
- Immunoglobulin-like domain superfamily
- Elafin-like superfamily
- Pancreatic trypsin inhibitor Kunitz domain superfamily
- Kunitz/Bovine pancreatic trypsin inhibitor domain
- WAP-type (Whey Acidic Protein) 'four-disulfide core'
- UNC-6/NTR/C345C module
- Immunoglobulin I-set domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of WFIKKN2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads WFIKKN2 as an antibody target. Whether an autoantibody or antibody against WFIKKN2 could matter depends on whether native WFIKKN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
WFIKKN2 is annotated as secreted, so native WFIKKN2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label WFIKKN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...